AIM ImmunoTech, Inc. (AIM)
1.18
-0.16
(-11.94%)
USD |
NYAM |
Jan 20, 16:00
1.20
+0.02
(+1.69%)
After-Hours: 20:00
AIM ImmunoTech Market Cap: 3.471M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 8.282B |
| Perspective Therapeutics, Inc. | 180.64M |
| Protalix Biotherapeutics, Inc. | 164.86M |
| Electromed, Inc. | 232.62M |
| Armata Pharmaceuticals, Inc. | 214.71M |
Market Cap Related Metrics
| PS Ratio | 194.40 |
| Price | 1.18 |
| Earnings Yield | -1.26K% |